Bradley Merrill Thompson of Epstein, Becker has posted his analysis of last week’s FDA draft guidance on select mobile applications [TA 21 July] at John Halamka MD’s Life as a Healthcare CIO blog. This is far more extensive than his posting on LinkedIn groups.